Cardiovascular Business
FDA Panel Questions Efficacy of First-Of-Its-Kind Heart Failure Device
BioPharma Dive
Blockbuster-To-Be Cardiovascular Drug Scores in Another Heart Study
JAMA Network Open
Cardiovascular Events 1 Year After Respiratory Syncytial Virus Infection in Adults
Clinical Brief
Blood Pressure Tablets Recalled After FDA Finds Contamination
Op-Med
Too Many Doctors Choose Specialties for Their 20s, and Regret It in Their 30s. Here's Why
Journal of the American College of Cardiology
Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients with Atrial Fibrillation Post-Transcatheter Aortic Valve Replacement
Sensible Medicine
Is Anticoagulation (Actually) More Dangerous Than Low-Dose Aspirin
Empagliflozin and Dapagliflozin Outcomes in Heart Failure
You're receiving this digest based on your specialty. Did we get it wrong? Update preferences here.
Download for iOS or Android.
Doximity.com • 500 3rd Street, Suite 510 • San Francisco, CA 94107
Unsubscribe from Doximity | Specialty News • Terms of Service • Privacy Policy
UUID: f0524f4b-fffb-439e-a789-9528596ac89c